Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Scottish injectable-drug manufacturer Symbiosis Pharmaceutical Services plans to expand its sterile filling facility.

CMO Symbiosis Expands Scotland Facility

At CPhI Worldwide 2015, The Dow Chemical Company announced the global commercial availability of AFFINISOL HPMC HME, a new generation of cellulosic polymer for drug solubilization. The polymer is designed for use by pharmaceutical companies looking to enhance the solubilization and inhibit the recrystallization of APIs in hot-melt extrusion (HME) formulations.

Dow’s New Excipient Is Designed for Hot-Melt Extrusion

Catalent Pharma Solutions won the “Innovation in Process and Formulation Development” category at the annual CPhI Pharma Awards, for its OptiShell softgel technology platform.

Catalent Softgel Technology Wins CPhI Award

The Quad Pulse Package PX dust collector from Camfil Air Pollution Control is a compact unit for processes that produce hazardous dusts in high concentrations, with a cleanable filter system that facilitates continuous manufacturing.

Collector Filters Hazardous Dust

Steris Corporation’s steam sterilizer provides reliable decontamination for high-containment facilities.

Laboratory Steam Sterilizer is Designed for High-Containment Facilities

Ajinomoto Althea, a biopharmaceutical CDMO, is expanding its existing biological drug product manufacturing operations to include highly active materials, such as antibody-drug conjugates (ADCs), the company announced on Oct. 14, 2015. The new facility is located in close proximity to the company’s existing operations in San Diego, CA.

Althea Builds Highly Potent Manufacturing Facility

The new sugars are touted to increase the efficacy of active pharmaceutical ingredients and improve cell culture yield.

Avantor Unveils New Sugars at CPhI

Cell Therapy Catapult will provide manufacturing scale-up services to enable Asterias’ future clinical trials and commercial supply for Asterias’ allogeneic dendritic cell immunotherapy, AST-VAC2.

Cell Therapy Catapult to Develop Process for Asterias Biotherapeutics

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Data protection for biologics is reduced from 12 to five years as a result of the Trans-Pacific Partnership agreement.

TPP Discussions Conclude; Biologics Now Have Shorter Data Protection Periods

The Cell History File is designed as a “cell passport” for developers and manufacturers of tissue- and cell-based medicinal products.